Patent · US Active

Solid pharmaceutical dosage formulation

US8377952B2 · kind B2 · utility

3Cited by

184References

35Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Joerg Rosenberg · Ellerstadt, DE
Ulrich Reinhold · Heidelberg, DE
Bernd Liepold · Dossenheim, DE
Gunther Berndl · Herxheim, DE
Jorg Breitenbach · Mannheim, DE
Laman Alani · Morristown, US
Soumojeet Ghosh · Gurnee, US

Key dates

Filing date	Feb 23, 2005
Grant date	Feb 19, 2013
Priority date	—
Expiry date	Oct 22, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/1635
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a pharmaceutical dosage formulation, and more particularly, to a pharmaceutical dosage formulation comprising an HIV protease inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.